Watson Pharma Private Limited is a wholly owned subsidiary of the Teva Group, world leader in the manufacture of api's and generic pharmaceuticals. Watson Pharma became part of Teva Group with effect from August 2016. 

The Site is spread across in 40,000 m2 area with a facility built-up area of 23,835 m2. This Integrated api Manufacturing site has state-of-the-art Infrastructure & Capability to handle complex Chemical reactions supported by integrated utilities and very well-equipped quality control laboratories. The site has two plants to manufacture large commercial products and a multi-purpose manufacturing plant designed to handle small volume and exhibit batches with overall capacity of 60-80 tons annually.

 

Key Successes:

  • Safety
    • Zero tolerance to Unsafe Act .
    • Zero discharge ETP facility
    • Accident free 5 million Hrs

6 years without any reportable injury

  • Quality
    • History of successful regulatory inspections
      • EDQM in March 2008, April 2013
      • DCGI in July 2013
      • USFDA in 2008, 2012, 2015, 2016 and 2018
      • FIMEA in October 2017
  • People
    • Stable, Experienced and Skilled workforce
    • Average tenure of 9 years

 

  • Innovation
    • In -house calibration of all measuring devices / instruments
    • Successful E-Batches with various complex reaction  capabilities

Contact Us >